 Shares of ADiTx Therapeutics Inc NASDAQ: ADTX are trading at a five-month high Thursday after ADiTx announced it would launch the AditxtScore Immune Monitoring Platform on Feb. 1. The initial application of the platform will be for providing more complete assessment of an individuals infection and immunity status with respect to the SARS-CoV-2 virus. 